🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The investigators hypothesize that early measurable residual disease (MRD)-...
Status
Recruiting
Location
Washington University School of Medicine
Start Date
2022-05-12
Trial ID
NCT04742634
Treatments Being Tested
The goal of this project is to see if two new potential treatments (defacti...
Status
Recruiting
Location
Prince of Wales Hospital
Start Date
2022-12-14
Trial ID
NCT05636514
Treatments Being Tested
HyPeR is a multi-centre Phase 1 Dose Escalation Study of Guadecitabine (SGI...
Status
Active Not Recruiting
Location
Royal Marsden Hospital
Start Date
2017-01-26
Trial ID
NCT02998567
Treatments Being Tested
The main aim of the study is to see if signs and symptoms of myelodysplasti...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-10-01
Trial ID
NCT04985656
Treatments Being Tested
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pha...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2023-03-09
Trial ID
NCT05728658
Background: Myelodysplastic syndromes (MDS) are diseases that affect the b...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2023-11-14
Trial ID
NCT05918055
Treatments Being Tested
This phase II trial studies the possible benefits of venetoclax and ASTX727...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2021-02-22
Trial ID
NCT04746235
Treatments Being Tested
A phase 1/2a, open-label, first-in-human study mainly aimed to evaluate the...
Status
Recruiting
Location
Local Institution - 0033
Start Date
2025-10-15
Trial ID
NCT07160725
Treatments Being Tested
Phase 1 dose escalation will determine the maximum tolerated dose (MTD) and...
Status
Recruiting
Location
City of Hope Comprehensive Cancer Center
Start Date
2019-11-05
Trial ID
NCT04065399
Treatments Being Tested
Activation of the RIG-I innate immune pathway and increased expression of t...
Status
Active Not Recruiting
Location
University of Colorado Hospital
Start Date
2022-06-20
Trial ID
NCT05089370
Treatments Being Tested